MAPK signaling pathway-targeted marine compounds in cancer therapy Jiaen WeiRuining LiuZunnan Huang Review – Cancer Research 03 January 2021 Pages: 3 - 22
Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres Katharina Carolin AlbrechtRené AschenbachUlf Teichgräber Original Article – Cancer Research Open access 02 September 2020 Pages: 23 - 32
High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA Duolan NarenTianyou YanYarong Li Original Article – Cancer Research 03 September 2020 Pages: 33 - 47
Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors Olga Y. BureninaNatalia L. LazarevichOlga A. Dontsova Original Article – Cancer Research 12 September 2020 Pages: 49 - 59
Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy Yasir G. MalikLars Gustav LyckanderDejan Ignjatovic Original Article – Cancer Research Open access 13 September 2020 Pages: 61 - 71
Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis Asim PervaizMichael ZeppHassan Adwan Original Article – Cancer Research Open access 09 September 2020 Pages: 73 - 91
Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B Yinan YangWencong TianZhi Qi Original Article – Cancer Research 08 September 2020 Pages: 93 - 103
Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma Yujing SunJunyi HePeng Gao Original Article – Cancer Research 23 September 2020 Pages: 105 - 115
Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria Jin Cheon KimJong Hwan KimYong Sung Kim Original Article – Cancer Research 22 September 2020 Pages: 117 - 128
B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma M. NientiedtK. MüllerM. C. Kriegmair Original Article – Cancer Research 19 September 2020 Pages: 129 - 138
Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses Yu JiangZixuan SuWenhua Liang Original Article – Cancer Research 23 September 2020 Pages: 139 - 151
An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning En-hui RenYa-jun DengQi-qi Xie Original Article – Cancer Research 23 September 2020 Pages: 153 - 165
MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines Wafaa M. RashedMohamed A. KandeilMohamed H. Abdel-Rahman Original Article – Cancer Research 26 September 2020 Pages: 167 - 175
Mendelian randomization study indicates lack of causal relationship between physical activity and lung cancer Wei XianJiayi ShenLi Zhang Original Article – Cancer Research 28 September 2020 Pages: 177 - 181
BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis Brenda Y. HernandezMobeen RahmanGillian Bryant-Greenwood Original Article – Cancer Research 29 September 2020 Pages: 183 - 194
Risk of lung cancer and renin–angiotensin blockade: a concise review Tobias RachowHelmut SchifflSusanne M. Lang Review – Clinical Oncology Open access 24 November 2020 Pages: 195 - 204
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers Dorothea HoseMartin SchrederStefan Knop Original Article – Clinical Oncology Open access 18 July 2020 Pages: 205 - 212
A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis Wonyoung ChoiYoungnam ChoYoungjoo Lee Original Article – Clinical Oncology 23 July 2020 Pages: 213 - 222
Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer Si-Si ChenKai LiXin Sun Original Article – Clinical Oncology 20 July 2020 Pages: 223 - 233
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) Thomas WiegelPeter AlbersMichael Stöckle Original Article – Clinical Oncology Open access 04 September 2020 Pages: 235 - 242
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) Thomas WiegelPeter AlbersMichael Stöckle Correction 21 December 2020 Pages: 243 - 244
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression Ken MasudaHidehito HorinouchiYuichiro Ohe Original Article – Clinical Oncology Open access 23 July 2020 Pages: 245 - 251
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide Kerstin BergerBernd TurowskiMarcel A. Kamp Original Article – Clinical Oncology Open access 03 August 2020 Pages: 253 - 262
Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system Daniela HirschTimo GaiserDeniz Gencer Original Article – Clinical Oncology Open access 09 August 2020 Pages: 263 - 273
A prediction model to evaluate the pretest risk of malignancy in solitary pulmonary nodules: evidence from a large Chinese southwestern population Zuohong WuTingting HuangBojiang Chen Original Article – Clinical Oncology 06 October 2020 Pages: 275 - 285
Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study Kosuke KashiwabaraShinji FujiiKazuhiko Sakamoto Original Article – Clinical Oncology 06 August 2020 Pages: 287 - 293
Peripheral blood T lymphocytosis in thymoma: an insight into immunobiology Shruti MishraSomanath PadhiGaurav Chhabra Letter to the Editor 09 November 2020 Pages: 295 - 301